Pictures from main event on health industry, Oslo Life Science 2019
-
Feb. 20, 2019The Women’s Choral Society of the University of Oslo with Inga Tangen Stensrud and Eirik Krokfjord.
They performed The Lapse of Time, an oratorio based on Charles Darwin’s On the Origin of Species. In the first part «Bones» we met Darwin wondering about the striking similarities between bones in the forelegs of various mammals. In the second part, we learned about the «Mistletoe» that struggles with other fruit-bearing plants to tempt birds. The lyrics are Darwin’s own, adapted by the composer Bjørn Morten Christophersen from the Department of Musicology at UiO.
-
Feb. 20, 2019Welcome – the latest news on the life science building at UiO and its role for science and health industry
Svein Stølen, Rector, UiO
-
Feb. 20, 2019Our chair for the first session was Andrea Winkler, Professor and Director of Centre for Global Health, the Faculty of Medicine, UiO.
We showed inspiring examples on collaboration between academia and industry that have benefitted patients and society.
-
Feb. 20, 2019Opening speech by Bayer – the company that bought Algeta, the number one life science success story of the University of Oslo
Kemal Malik, Board of Management of Bayer AG responsible for innovation
-
Feb. 20, 2019FinnGen – a unique collaboration between academia and industry to find the next breakthroughs in disease prevention, diagnosis and treatment
Aarno Palotie, Research Director, Institute for Molecular Medicine Finland (FIMM), HiLIFE, University of Helsinki; Faculty member, Center for Human Genome Research at the Massachusetts General Hospital; Associate member, Broad Institute of MIT and Harvard
-
Feb. 20, 2019Innovation and industry collaboration in translational research – lessons learned from Finnish FIMM to inspire the Norwegian NCMM and the life science community in Oslo
Janna Saarela, the new Director of the Centre for Molecular Medicine Norway (NCMM), UiO, who comes from Institute for Molecular Medicine Finland (FIMM)
-
Feb. 20, 2019Nt-proBNP – the biomarker for heart failure that conquered the world from Oslo – from the researcher´s perspective
Professor II Christian Hall, University of Oslo and Vestre Viken Hospital Trust
From 9:20 we get the company's perspective from Mathias Egermark, MD, Senior Vice President, Life Cycle Leader Cardiac, Women's Health & Personalised Healthcare Solutions, Roche Diagnostics International
-
Feb. 20, 2019Nt-proBNP – the biomarker for heart failure that conquered the world from Oslo – from the company's perspective
Mathias Egermark, MD, Senior Vice President, Life Cycle Leader Cardiac, Women's Health & Personalised Healthcare Solutions, Roche Diagnostics International
Watch his presentation in this video from 9:20.
First we get the researcher's perspective from Professor II Christian Hall, University of Oslo and Vestre Viken Hospital Trust.
-
Feb. 20, 2019Cutting edge technology for the benefit of patients and society from successful collaboration between the intervention centre at Oslo University Hospital and Siemens
Anne Figel, Director Global Marketing Neurosurgery, Trauma and Orthopedics at Siemens Healthineers
-
Feb. 20, 2019Our chair for the second session was Jutta Heix from Oslo Cancer Cluster.
We showed the journey from academia to industry with pitches from entrepreneurs in Oslo. The projects were selected from UiO:Life Science's innovation programme for health related life sciences SPARK Norway, Oslo Cancer Cluster and Norway Health Tech.
Panel: Morten Egeberg, UiO:Life Science, Daniel Malarek, Roche, and Rannveig Fadum, Innovation Norway.
-
-
Feb. 21, 2019 -
Feb. 20, 2019Gjermund Henriksen, Professor II, and team leader SPARK Norway project
-
Feb. 20, 2019Simone Mester, PhD student, UiO/OUS and team leader SPARK Norway project
-
Feb. 20, 2019Jean-Luc Boulland, Researcher, Norwegian Center for Stem Cell Research, UiO/OUS and team leader SPARK Norway project
-
Feb. 20, 2019Claudia Alejandra McDonald Bøen, PhD, CEO, Arctic Pharma AS
-
-
-
Feb. 20, 2019Session 3: Presentation and debate on the new white paper on health industry
First: The new white paper on health industry
Presented by Bent Høie, Minister of Health
-
Feb. 20, 2019Debate on lessons learned from the examples we’ve heard – and a new era with the new white paper on health industry
Moderator for the debate: Markus Moe, Editor-in-chief, Dagens Medisin
Panel: Bent Høie, Minister of Health • Ingvild Kjerkol, Labour Party Member of the Storting • Per Morten Sandset, Vice-Rector Research and Innovation, UiO • Kathrine Myhre, CEO, Norway Health Tech • Ketil Widerberg, General Manager, Oslo Cancer Cluster
-
Feb. 20, 2019
